The concise health risk tracking-self report: psychometrics within a placebo-controlled antidepressant trial among depressed outpatients
The selective orexin-2 receptor antagonist seltorexant improves sleep: An exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia